Homoeopathy for Menieres disease
Phase 1
- Conditions
- Health Condition 1: H823- Vertiginous syndromes in diseasesclassified elsewhere, bilateral
- Registration Number
- CTRI/2024/01/061526
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of either sex above 15 years of age
2.Two or more episodes of vertigo or dizziness, each lasting 20 minutes to 24 hours.
3.Fluctuating aural symptoms (hearing, tinnitus or fullness) in the affected ear.
Exclusion Criteria
1.All other vesibular causes like Vestibular paroxysmia, Vestibular migraine, Transient ischemic attacks, Endolymphatic sac tumor, and Chronic subjective dizziness will be excluded based on the clinical features and MRI brain [if indicated].
2.Pregnant women.
3.Persons addicted to narcotic substances.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ménière’s disease patient-oriented severity index [MD-POSI]Timepoint: At 3 months interval
- Secondary Outcome Measures
Name Time Method . Audiometry – Pure Tone Average [PTA] <br/ ><br>2. Frequency of vertigo – X/Y×100. X is the average number of vertigo spells per month for the six months 18-24 months after therapy and Y is the average number of vertigo spells per month for the six months before therapy. <br/ ><br>Timepoint: At baseline and at the end of study